Minerva Neurosciences, Inc. (NERV)
NASDAQ·Healthcare·Biotechnology
$6.45
+0.31%
Mkt Cap $55.94M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 11, 2026 | — | — | — | -$0.11 | -$0.64 | -481.82% | — | — |
| Q4 2025 Nov 5, 2025 | — | — | — | -$0.35 | -$0.36 | -2.86% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.95 | -$0.43 | +54.74% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$1.07 | -$0.50 | +53.27% | — | — |
| Q1 2025 Feb 25, 2025 | — | $42.22K | — | -$1.05 | -$0.56 | +46.67% | — | — |
| Q4 2024 Nov 5, 2024 | — | — | — | -$1.01 | $2.97 | +394.06% | — | — |
| Q3 2024 Aug 6, 2024 | — | — | — | -$0.97 | -$1.09 | -12.37% | — | — |
| Q2 2024 May 1, 2024 | — | — | — | -$1.20 | -$1.13 | +5.83% | — | — |
| Q1 2024 Feb 22, 2024 | — | — | — | -$0.88 | -$1.19 | -35.23% | — | — |
| Q4 2023 Nov 7, 2023 | — | — | — | -$0.77 | -$1.03 | -33.77% | — | — |
| Q3 2023 Aug 1, 2023 | — | — | — | -$0.44 | -$1.12 | -154.55% | — | — |
| Q2 2023 May 15, 2023 | — | — | — | -$1.63 | -$1.31 | +19.63% | — | — |
| Q1 2023 Mar 8, 2023 | — | — | — | -$1.35 | -$1.26 | +6.67% | — | — |
| Q4 2022 Nov 9, 2022 | — | — | — | -$1.46 | -$1.29 | +11.64% | — | — |
| Q3 2022 Aug 9, 2022 | — | — | — | -$1.84 | -$1.63 | +11.41% | — | — |
| Q2 2022 May 4, 2022 | — | — | — | -$1.60 | -$1.84 | -15.00% | — | — |
| Q1 2022 Mar 1, 2022 | $333.33K | — | — | -$1.60 | -$0.96 | +40.00% | — | — |
| Q4 2021 Nov 8, 2021 | $330.00K | — | — | -$1.76 | -$1.76 | +0.00% | — | — |
| Q3 2021 Aug 2, 2021 | $570.00K | — | — | -$1.36 | -$2.00 | -47.06% | — | — |
| Q2 2021 May 12, 2021 | — | — | — | $1.60 | -$1.68 | -205.00% | — | — |